Stefanie Sarantopoulos, MD, PhD

Associate Professor of Medicine
Assistant Professor of Immunology
Member of the Duke Cancer Institute
Campus mail 152 Jones Bldg, Box 3961, Durham, NC 27710
Email address stefanie.sarantopoulos@duke.edu
In Their Words

Education and Training

  • Fellowship, Hematology/ Oncology, Dana Farber Cancer Institute, 2002 - 2005
  • Chief Resident, Internal Medicine, Boston University School of Medicine, 2001 - 2002
  • Resident, Internal Medicine, Boston University School of Medicine, 1999 - 2001
  • Intern, Internal Medicine, Boston University School of Medicine, 1998 - 1999
  • Ph.D., Boston University School of Medicine, 1998
  • M.D., Boston University, 1998

Publications

Cutler, Corey, Haesook T. Kim, Bhavjot Bindra, Stefanie Sarantopoulos, Vincent T. Ho, Yi-Bin Chen, Jacalyn Rosenblatt, et al. “Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial..” Blood 122, no. 8 (August 22, 2013): 1510–17. https://doi.org/10.1182/blood-2013-04-495895.

PMID
23861248
Full Text

Wood, W. A., J. Whitley, R. Goyal, P. M. Brown, A. Sharf, R. Irons, K. V. Rao, et al. “Effectiveness of etoposide chemomobilization in lymphoma patients undergoing auto-SCT..” Bone Marrow Transplant 48, no. 6 (June 2013): 771–76. https://doi.org/10.1038/bmt.2012.216.

PMID
23165501
Full Text

Allen, Jessica L., George Fedoriw, Jenna Wooten, Matthew Fore, Philip A. Roehrs, Paul Armistead, James Coghill, et al. “Increased BLNK and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets.” In Biology of Blood and Marrow Transplantation, 19:S136–37. Elsevier BV, 2013. https://doi.org/10.1016/j.bbmt.2012.11.075.

Full Text

Wood, William A., Allison M. Deal, Bryce B. Reeve, Amy P. Abernethy, Claudio L. Battaglini, Yoon Hie Kim, Julia S. Whitley, et al. “Feasibility of Daily and Weekly Symptom and Health-Related Quality of Life (HRQOL) Surveillance in Patients Receiving Hematopoietic Cell Transplantation (HCT).” In Blood, Vol. 120. AMER SOC HEMATOLOGY, 2012.

Scholars@Duke

Wood, William A., Allison M. Deal, Claudio L. Battaglini, Bryce B. Reeve, Amy P. Abernethy, Yoon Hie Kim, Julia S. Whitley, et al. “Feasibility and Prognostic Value of VO2(peak) in Patients Undergoing Hematopoietic Cell Transplantation (HCT).” In Blood, Vol. 120. AMER SOC HEMATOLOGY, 2012.

Scholars@Duke

Wood, William A., Allison M. Deal, Claudio L. Battaglini, Bryce B. Reeve, Amy P. Abernethy, Yoon Hie Kim, Julia S. Whitley, et al. “Feasibility and Prognostic Value of VO2(peak) in Patients Undergoing Hematopoietic Cell Transplantation (HCT).” In Blood, Vol. 120, 2012.

Scholars@Duke

Allen, Jessica L., Matthew S. Fore, Jenna Wooten, Philip A. Roehrs, Nazmim S. Bhuiya, Todd Hoffert, Andrew Sharf, et al. “B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways..” Blood 120, no. 12 (September 20, 2012): 2529–36. https://doi.org/10.1182/blood-2012-06-438911.

PMID
22896003
Full Text

Fedoriw, Yuri, T Danielle Samulski, Allison M. Deal, Cherie H. Dunphy, Andrew Sharf, Thomas C. Shea, Jonathan S. Serody, and Stefanie Sarantopoulos. “Bone marrow B cell precursor number after allogeneic stem cell transplantation and GVHD development..” Biol Blood Marrow Transplant 18, no. 6 (June 2012): 968–73. https://doi.org/10.1016/j.bbmt.2012.03.005.

PMID
22446015
Full Text

Pages